Global Artificial Blood Substitute Supply, Demand and Key Producers, 2026-2032
The global Artificial Blood Substitute market size is expected to reach $ 46.61 million by 2032, rising at a market growth of 17.2% CAGR during the forecast period (2026-2032).
Artificial Blood Substitute refers to a class of biomedical products designed to partially replicate the essential physiological functions of human blood—primarily oxygen transport and delivery—without relying on donated human blood. These products are intended to provide temporary or supportive oxygen-carrying capacity in situations where conventional blood transfusion is unavailable, impractical, or contraindicated.
The market for artificial blood substitutes is primarily driven by increasing medical demand and advancements in technology. On a global scale, the demand for blood transfusions continues to rise, while the availability of suitable blood is often constrained by challenges such as blood type compatibility, limited shelf life, and underdeveloped blood supply systems. Artificial blood substitutes can play a vital role in emergency care, mass casualty incidents, and battlefield medicine. In addition, the accelerating aging population, along with the growing number of major surgeries and trauma cases, has created strong clinical demand for safe, long-lasting, and universally compatible alternatives. Advances in bioengineering, nanotechnology, and synthetic biology are also fostering the development of more efficient and stable products. Furthermore, concerns over transfusion-related infections and low blood donation rates in certain regions are encouraging healthcare systems to prioritize artificial blood solutions, collectively driving market growth.
The global key companies of Artificial Blood Substitute include Perftoran, HbO2 Therapeutics, Hemarina, Aurum Biosciences Ltd., KaloCyte Inc., Prolong Pharmaceuticals, NuvOx Pharma, etc. In 2025, the global two largest players hold a share approximately 92% in terms of revenue.
This report studies the global Artificial Blood Substitute demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Artificial Blood Substitute, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Artificial Blood Substitute that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Artificial Blood Substitute total market, 2021-2032, (USD Million)
Global Artificial Blood Substitute total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Artificial Blood Substitute total market, key domestic companies, and share, (USD Million)
Global Artificial Blood Substitute revenue by player, revenue and market share 2021-2026, (USD Million)
Global Artificial Blood Substitute total market by Type, CAGR, 2021-2032, (USD Million)
Global Artificial Blood Substitute total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Artificial Blood Substitute market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Perftoran, HbO2 Therapeutics, Aurum Biosciences Ltd., Hemarina, KaloCyte Inc., Prolong Pharmaceuticals, NuvOx Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Artificial Blood Substitute market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Artificial Blood Substitute Market, By Region:
1. How big is the global Artificial Blood Substitute market?
2. What is the demand of the global Artificial Blood Substitute market?
3. What is the year over year growth of the global Artificial Blood Substitute market?
4. What is the total value of the global Artificial Blood Substitute market?
5. Who are the Major Players in the global Artificial Blood Substitute market?
6. What are the growth factors driving the market demand?
Artificial Blood Substitute refers to a class of biomedical products designed to partially replicate the essential physiological functions of human blood—primarily oxygen transport and delivery—without relying on donated human blood. These products are intended to provide temporary or supportive oxygen-carrying capacity in situations where conventional blood transfusion is unavailable, impractical, or contraindicated.
The market for artificial blood substitutes is primarily driven by increasing medical demand and advancements in technology. On a global scale, the demand for blood transfusions continues to rise, while the availability of suitable blood is often constrained by challenges such as blood type compatibility, limited shelf life, and underdeveloped blood supply systems. Artificial blood substitutes can play a vital role in emergency care, mass casualty incidents, and battlefield medicine. In addition, the accelerating aging population, along with the growing number of major surgeries and trauma cases, has created strong clinical demand for safe, long-lasting, and universally compatible alternatives. Advances in bioengineering, nanotechnology, and synthetic biology are also fostering the development of more efficient and stable products. Furthermore, concerns over transfusion-related infections and low blood donation rates in certain regions are encouraging healthcare systems to prioritize artificial blood solutions, collectively driving market growth.
The global key companies of Artificial Blood Substitute include Perftoran, HbO2 Therapeutics, Hemarina, Aurum Biosciences Ltd., KaloCyte Inc., Prolong Pharmaceuticals, NuvOx Pharma, etc. In 2025, the global two largest players hold a share approximately 92% in terms of revenue.
This report studies the global Artificial Blood Substitute demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Artificial Blood Substitute, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Artificial Blood Substitute that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Artificial Blood Substitute total market, 2021-2032, (USD Million)
Global Artificial Blood Substitute total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Artificial Blood Substitute total market, key domestic companies, and share, (USD Million)
Global Artificial Blood Substitute revenue by player, revenue and market share 2021-2026, (USD Million)
Global Artificial Blood Substitute total market by Type, CAGR, 2021-2032, (USD Million)
Global Artificial Blood Substitute total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Artificial Blood Substitute market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Perftoran, HbO2 Therapeutics, Aurum Biosciences Ltd., Hemarina, KaloCyte Inc., Prolong Pharmaceuticals, NuvOx Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Artificial Blood Substitute market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Artificial Blood Substitute Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Perfluorocarbon-based Oxygen Carrier (PFBOC)
- Hemoglobin-based Oxygen Carrier (HBOC)
- Preclinical Stage
- Clinical Trial Stage
- Commercialization
- Solution-Based
- Emulsion-Based
- Others
- Military
- Civil
- Perftoran
- HbO2 Therapeutics
- Aurum Biosciences Ltd.
- Hemarina
- KaloCyte Inc.
- Prolong Pharmaceuticals
- NuvOx Pharma
1. How big is the global Artificial Blood Substitute market?
2. What is the demand of the global Artificial Blood Substitute market?
3. What is the year over year growth of the global Artificial Blood Substitute market?
4. What is the total value of the global Artificial Blood Substitute market?
5. Who are the Major Players in the global Artificial Blood Substitute market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Artificial Blood Substitute Introduction
1.2 World Artificial Blood Substitute Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Artificial Blood Substitute Total Market by Region (by Headquarter Location)
1.3.1 World Artificial Blood Substitute Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Artificial Blood Substitute Revenue (2021-2032)
1.3.3 China Based Company Artificial Blood Substitute Revenue (2021-2032)
1.3.4 Europe Based Company Artificial Blood Substitute Revenue (2021-2032)
1.3.5 Japan Based Company Artificial Blood Substitute Revenue (2021-2032)
1.3.6 South Korea Based Company Artificial Blood Substitute Revenue (2021-2032)
1.3.7 ASEAN Based Company Artificial Blood Substitute Revenue (2021-2032)
1.3.8 India Based Company Artificial Blood Substitute Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Artificial Blood Substitute Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Artificial Blood Substitute Consumption Value (2021-2032)
2.2 World Artificial Blood Substitute Consumption Value by Region
2.2.1 World Artificial Blood Substitute Consumption Value by Region (2021-2026)
2.2.2 World Artificial Blood Substitute Consumption Value Forecast by Region (2027-2032)
2.3 United States Artificial Blood Substitute Consumption Value (2021-2032)
2.4 China Artificial Blood Substitute Consumption Value (2021-2032)
2.5 Europe Artificial Blood Substitute Consumption Value (2021-2032)
2.6 Japan Artificial Blood Substitute Consumption Value (2021-2032)
2.7 South Korea Artificial Blood Substitute Consumption Value (2021-2032)
2.8 ASEAN Artificial Blood Substitute Consumption Value (2021-2032)
2.9 India Artificial Blood Substitute Consumption Value (2021-2032)
3 WORLD ARTIFICIAL BLOOD SUBSTITUTE COMPANIES COMPETITIVE ANALYSIS
3.1 World Artificial Blood Substitute Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Artificial Blood Substitute Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Artificial Blood Substitute in 2025
3.2.3 Global Concentration Ratios (CR8) for Artificial Blood Substitute in 2025
3.3 Artificial Blood Substitute Company Evaluation Quadrant
3.4 Artificial Blood Substitute Market: Overall Company Footprint Analysis
3.4.1 Artificial Blood Substitute Market: Region Footprint
3.4.2 Artificial Blood Substitute Market: Company Product Type Footprint
3.4.3 Artificial Blood Substitute Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Artificial Blood Substitute Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Artificial Blood Substitute Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Artificial Blood Substitute Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Artificial Blood Substitute Consumption Value Comparison
4.2.1 United States VS China: Artificial Blood Substitute Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Artificial Blood Substitute Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Artificial Blood Substitute Companies and Market Share, 2021-2026
4.3.1 United States Based Artificial Blood Substitute Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Artificial Blood Substitute Revenue, (2021-2026)
4.4 China Based Companies Artificial Blood Substitute Revenue and Market Share, 2021-2026
4.4.1 China Based Artificial Blood Substitute Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Artificial Blood Substitute Revenue, (2021-2026)
4.5 Rest of World Based Artificial Blood Substitute Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Artificial Blood Substitute Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Artificial Blood Substitute Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Artificial Blood Substitute Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Perfluorocarbon-based Oxygen Carrier (PFBOC)
5.2.2 Hemoglobin-based Oxygen Carrier (HBOC)
5.3 Market Segment by Type
5.3.1 World Artificial Blood Substitute Market Size by Type (2021-2026)
5.3.2 World Artificial Blood Substitute Market Size by Type (2027-2032)
5.3.3 World Artificial Blood Substitute Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY STAGE
6.1 World Artificial Blood Substitute Market Size Overview by Stage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Stage
6.2.1 Preclinical Stage
6.2.2 Clinical Trial Stage
6.2.3 Commercialization
6.3 Market Segment by Stage
6.3.1 World Artificial Blood Substitute Market Size by Stage (2021-2026)
6.3.2 World Artificial Blood Substitute Market Size by Stage (2027-2032)
6.3.3 World Artificial Blood Substitute Market Size Market Share by Stage (2027-2032)
7 MARKET ANALYSIS BY PRODUCT FORM
7.1 World Artificial Blood Substitute Market Size Overview by Product Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Form
7.2.1 Solution-Based
7.2.2 Emulsion-Based
7.2.3 Others
7.3 Market Segment by Product Form
7.3.1 World Artificial Blood Substitute Market Size by Product Form (2021-2026)
7.3.2 World Artificial Blood Substitute Market Size by Product Form (2027-2032)
7.3.3 World Artificial Blood Substitute Market Size Market Share by Product Form (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Artificial Blood Substitute Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Military
8.2.2 Civil
8.3 Market Segment by Application
8.3.1 World Artificial Blood Substitute Market Size by Application (2021-2026)
8.3.2 World Artificial Blood Substitute Market Size by Application (2027-2032)
8.3.3 World Artificial Blood Substitute Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Perftoran
9.1.1 Perftoran Details
9.1.2 Perftoran Major Business
9.1.3 Perftoran Artificial Blood Substitute Product and Services
9.1.4 Perftoran Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Perftoran Recent Developments/Updates
9.1.6 Perftoran Competitive Strengths & Weaknesses
9.2 HbO2 Therapeutics
9.2.1 HbO2 Therapeutics Details
9.2.2 HbO2 Therapeutics Major Business
9.2.3 HbO2 Therapeutics Artificial Blood Substitute Product and Services
9.2.4 HbO2 Therapeutics Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 HbO2 Therapeutics Recent Developments/Updates
9.2.6 HbO2 Therapeutics Competitive Strengths & Weaknesses
9.3 Aurum Biosciences Ltd.
9.3.1 Aurum Biosciences Ltd. Details
9.3.2 Aurum Biosciences Ltd. Major Business
9.3.3 Aurum Biosciences Ltd. Artificial Blood Substitute Product and Services
9.3.4 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Aurum Biosciences Ltd. Recent Developments/Updates
9.3.6 Aurum Biosciences Ltd. Competitive Strengths & Weaknesses
9.4 Hemarina
9.4.1 Hemarina Details
9.4.2 Hemarina Major Business
9.4.3 Hemarina Artificial Blood Substitute Product and Services
9.4.4 Hemarina Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Hemarina Recent Developments/Updates
9.4.6 Hemarina Competitive Strengths & Weaknesses
9.5 KaloCyte Inc.
9.5.1 KaloCyte Inc. Details
9.5.2 KaloCyte Inc. Major Business
9.5.3 KaloCyte Inc. Artificial Blood Substitute Product and Services
9.5.4 KaloCyte Inc. Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 KaloCyte Inc. Recent Developments/Updates
9.5.6 KaloCyte Inc. Competitive Strengths & Weaknesses
9.6 Prolong Pharmaceuticals
9.6.1 Prolong Pharmaceuticals Details
9.6.2 Prolong Pharmaceuticals Major Business
9.6.3 Prolong Pharmaceuticals Artificial Blood Substitute Product and Services
9.6.4 Prolong Pharmaceuticals Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Prolong Pharmaceuticals Recent Developments/Updates
9.6.6 Prolong Pharmaceuticals Competitive Strengths & Weaknesses
9.7 NuvOx Pharma
9.7.1 NuvOx Pharma Details
9.7.2 NuvOx Pharma Major Business
9.7.3 NuvOx Pharma Artificial Blood Substitute Product and Services
9.7.4 NuvOx Pharma Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 NuvOx Pharma Recent Developments/Updates
9.7.6 NuvOx Pharma Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Artificial Blood Substitute Industry Chain
10.2 Artificial Blood Substitute Upstream Analysis
10.3 Artificial Blood Substitute Midstream Analysis
10.4 Artificial Blood Substitute Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Artificial Blood Substitute Introduction
1.2 World Artificial Blood Substitute Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Artificial Blood Substitute Total Market by Region (by Headquarter Location)
1.3.1 World Artificial Blood Substitute Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Artificial Blood Substitute Revenue (2021-2032)
1.3.3 China Based Company Artificial Blood Substitute Revenue (2021-2032)
1.3.4 Europe Based Company Artificial Blood Substitute Revenue (2021-2032)
1.3.5 Japan Based Company Artificial Blood Substitute Revenue (2021-2032)
1.3.6 South Korea Based Company Artificial Blood Substitute Revenue (2021-2032)
1.3.7 ASEAN Based Company Artificial Blood Substitute Revenue (2021-2032)
1.3.8 India Based Company Artificial Blood Substitute Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Artificial Blood Substitute Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Artificial Blood Substitute Consumption Value (2021-2032)
2.2 World Artificial Blood Substitute Consumption Value by Region
2.2.1 World Artificial Blood Substitute Consumption Value by Region (2021-2026)
2.2.2 World Artificial Blood Substitute Consumption Value Forecast by Region (2027-2032)
2.3 United States Artificial Blood Substitute Consumption Value (2021-2032)
2.4 China Artificial Blood Substitute Consumption Value (2021-2032)
2.5 Europe Artificial Blood Substitute Consumption Value (2021-2032)
2.6 Japan Artificial Blood Substitute Consumption Value (2021-2032)
2.7 South Korea Artificial Blood Substitute Consumption Value (2021-2032)
2.8 ASEAN Artificial Blood Substitute Consumption Value (2021-2032)
2.9 India Artificial Blood Substitute Consumption Value (2021-2032)
3 WORLD ARTIFICIAL BLOOD SUBSTITUTE COMPANIES COMPETITIVE ANALYSIS
3.1 World Artificial Blood Substitute Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Artificial Blood Substitute Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Artificial Blood Substitute in 2025
3.2.3 Global Concentration Ratios (CR8) for Artificial Blood Substitute in 2025
3.3 Artificial Blood Substitute Company Evaluation Quadrant
3.4 Artificial Blood Substitute Market: Overall Company Footprint Analysis
3.4.1 Artificial Blood Substitute Market: Region Footprint
3.4.2 Artificial Blood Substitute Market: Company Product Type Footprint
3.4.3 Artificial Blood Substitute Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Artificial Blood Substitute Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Artificial Blood Substitute Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Artificial Blood Substitute Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Artificial Blood Substitute Consumption Value Comparison
4.2.1 United States VS China: Artificial Blood Substitute Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Artificial Blood Substitute Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Artificial Blood Substitute Companies and Market Share, 2021-2026
4.3.1 United States Based Artificial Blood Substitute Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Artificial Blood Substitute Revenue, (2021-2026)
4.4 China Based Companies Artificial Blood Substitute Revenue and Market Share, 2021-2026
4.4.1 China Based Artificial Blood Substitute Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Artificial Blood Substitute Revenue, (2021-2026)
4.5 Rest of World Based Artificial Blood Substitute Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Artificial Blood Substitute Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Artificial Blood Substitute Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Artificial Blood Substitute Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Perfluorocarbon-based Oxygen Carrier (PFBOC)
5.2.2 Hemoglobin-based Oxygen Carrier (HBOC)
5.3 Market Segment by Type
5.3.1 World Artificial Blood Substitute Market Size by Type (2021-2026)
5.3.2 World Artificial Blood Substitute Market Size by Type (2027-2032)
5.3.3 World Artificial Blood Substitute Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY STAGE
6.1 World Artificial Blood Substitute Market Size Overview by Stage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Stage
6.2.1 Preclinical Stage
6.2.2 Clinical Trial Stage
6.2.3 Commercialization
6.3 Market Segment by Stage
6.3.1 World Artificial Blood Substitute Market Size by Stage (2021-2026)
6.3.2 World Artificial Blood Substitute Market Size by Stage (2027-2032)
6.3.3 World Artificial Blood Substitute Market Size Market Share by Stage (2027-2032)
7 MARKET ANALYSIS BY PRODUCT FORM
7.1 World Artificial Blood Substitute Market Size Overview by Product Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Form
7.2.1 Solution-Based
7.2.2 Emulsion-Based
7.2.3 Others
7.3 Market Segment by Product Form
7.3.1 World Artificial Blood Substitute Market Size by Product Form (2021-2026)
7.3.2 World Artificial Blood Substitute Market Size by Product Form (2027-2032)
7.3.3 World Artificial Blood Substitute Market Size Market Share by Product Form (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Artificial Blood Substitute Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Military
8.2.2 Civil
8.3 Market Segment by Application
8.3.1 World Artificial Blood Substitute Market Size by Application (2021-2026)
8.3.2 World Artificial Blood Substitute Market Size by Application (2027-2032)
8.3.3 World Artificial Blood Substitute Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Perftoran
9.1.1 Perftoran Details
9.1.2 Perftoran Major Business
9.1.3 Perftoran Artificial Blood Substitute Product and Services
9.1.4 Perftoran Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Perftoran Recent Developments/Updates
9.1.6 Perftoran Competitive Strengths & Weaknesses
9.2 HbO2 Therapeutics
9.2.1 HbO2 Therapeutics Details
9.2.2 HbO2 Therapeutics Major Business
9.2.3 HbO2 Therapeutics Artificial Blood Substitute Product and Services
9.2.4 HbO2 Therapeutics Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 HbO2 Therapeutics Recent Developments/Updates
9.2.6 HbO2 Therapeutics Competitive Strengths & Weaknesses
9.3 Aurum Biosciences Ltd.
9.3.1 Aurum Biosciences Ltd. Details
9.3.2 Aurum Biosciences Ltd. Major Business
9.3.3 Aurum Biosciences Ltd. Artificial Blood Substitute Product and Services
9.3.4 Aurum Biosciences Ltd. Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Aurum Biosciences Ltd. Recent Developments/Updates
9.3.6 Aurum Biosciences Ltd. Competitive Strengths & Weaknesses
9.4 Hemarina
9.4.1 Hemarina Details
9.4.2 Hemarina Major Business
9.4.3 Hemarina Artificial Blood Substitute Product and Services
9.4.4 Hemarina Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Hemarina Recent Developments/Updates
9.4.6 Hemarina Competitive Strengths & Weaknesses
9.5 KaloCyte Inc.
9.5.1 KaloCyte Inc. Details
9.5.2 KaloCyte Inc. Major Business
9.5.3 KaloCyte Inc. Artificial Blood Substitute Product and Services
9.5.4 KaloCyte Inc. Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 KaloCyte Inc. Recent Developments/Updates
9.5.6 KaloCyte Inc. Competitive Strengths & Weaknesses
9.6 Prolong Pharmaceuticals
9.6.1 Prolong Pharmaceuticals Details
9.6.2 Prolong Pharmaceuticals Major Business
9.6.3 Prolong Pharmaceuticals Artificial Blood Substitute Product and Services
9.6.4 Prolong Pharmaceuticals Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Prolong Pharmaceuticals Recent Developments/Updates
9.6.6 Prolong Pharmaceuticals Competitive Strengths & Weaknesses
9.7 NuvOx Pharma
9.7.1 NuvOx Pharma Details
9.7.2 NuvOx Pharma Major Business
9.7.3 NuvOx Pharma Artificial Blood Substitute Product and Services
9.7.4 NuvOx Pharma Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 NuvOx Pharma Recent Developments/Updates
9.7.6 NuvOx Pharma Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Artificial Blood Substitute Industry Chain
10.2 Artificial Blood Substitute Upstream Analysis
10.3 Artificial Blood Substitute Midstream Analysis
10.4 Artificial Blood Substitute Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Artificial Blood Substitute Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Artificial Blood Substitute Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Artificial Blood Substitute Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Artificial Blood Substitute Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Artificial Blood Substitute Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Artificial Blood Substitute Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Artificial Blood Substitute Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Artificial Blood Substitute Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Artificial Blood Substitute Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Artificial Blood Substitute Players in 2025
Table 12. World Artificial Blood Substitute Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Artificial Blood Substitute Company Evaluation Quadrant
Table 14. Head Office of Key Artificial Blood Substitute Players
Table 15. Artificial Blood Substitute Market: Company Product Type Footprint
Table 16. Artificial Blood Substitute Market: Company Product Application Footprint
Table 17. Artificial Blood Substitute Mergers & Acquisitions Activity
Table 18. United States VS China Artificial Blood Substitute Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Artificial Blood Substitute Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Artificial Blood Substitute Companies, Headquarters (States, Country)
Table 21. United States Based Companies Artificial Blood Substitute Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Artificial Blood Substitute Revenue Market Share (2021-2026)
Table 23. China Based Artificial Blood Substitute Companies, Headquarters (Province, Country)
Table 24. China Based Companies Artificial Blood Substitute Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Artificial Blood Substitute Revenue Market Share (2021-2026)
Table 26. Rest of World Based Artificial Blood Substitute Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Artificial Blood Substitute Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Artificial Blood Substitute Revenue Market Share (2021-2026)
Table 29. World Artificial Blood Substitute Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Artificial Blood Substitute Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Artificial Blood Substitute Market Size by Type (2027-2032) & (USD Million)
Table 32. World Artificial Blood Substitute Market Size by Stage, (USD Million), 2021 & 2025 & 2032
Table 33. World Artificial Blood Substitute Market Size Value by Stage (2021-2026) & (USD Million)
Table 34. World Artificial Blood Substitute Market Size by Stage (2027-2032) & (USD Million)
Table 35. World Artificial Blood Substitute Market Size by Product Form, (USD Million), 2021 & 2025 & 2032
Table 36. World Artificial Blood Substitute Market Size Value by Product Form (2021-2026) & (USD Million)
Table 37. World Artificial Blood Substitute Market Size by Product Form (2027-2032) & (USD Million)
Table 38. World Artificial Blood Substitute Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Artificial Blood Substitute Market Size by Application (2021-2026) & (USD Million)
Table 40. World Artificial Blood Substitute Market Size by Application (2027-2032) & (USD Million)
Table 41. Perftoran Basic Information, Manufacturing Base and Competitors
Table 42. Perftoran Major Business
Table 43. Perftoran Artificial Blood Substitute Product and Services
Table 44. Perftoran Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Perftoran Recent Developments/Updates
Table 46. Perftoran Competitive Strengths & Weaknesses
Table 47. HbO2 Therapeutics Basic Information, Manufacturing Base and Competitors
Table 48. HbO2 Therapeutics Major Business
Table 49. HbO2 Therapeutics Artificial Blood Substitute Product and Services
Table 50. HbO2 Therapeutics Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. HbO2 Therapeutics Recent Developments/Updates
Table 52. HbO2 Therapeutics Competitive Strengths & Weaknesses
Table 53. Aurum Biosciences Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Aurum Biosciences Ltd. Major Business
Table 55. Aurum Biosciences Ltd. Artificial Blood Substitute Product and Services
Table 56. Aurum Biosciences Ltd. Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Aurum Biosciences Ltd. Recent Developments/Updates
Table 58. Aurum Biosciences Ltd. Competitive Strengths & Weaknesses
Table 59. Hemarina Basic Information, Manufacturing Base and Competitors
Table 60. Hemarina Major Business
Table 61. Hemarina Artificial Blood Substitute Product and Services
Table 62. Hemarina Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Hemarina Recent Developments/Updates
Table 64. Hemarina Competitive Strengths & Weaknesses
Table 65. KaloCyte Inc. Basic Information, Manufacturing Base and Competitors
Table 66. KaloCyte Inc. Major Business
Table 67. KaloCyte Inc. Artificial Blood Substitute Product and Services
Table 68. KaloCyte Inc. Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. KaloCyte Inc. Recent Developments/Updates
Table 70. KaloCyte Inc. Competitive Strengths & Weaknesses
Table 71. Prolong Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 72. Prolong Pharmaceuticals Major Business
Table 73. Prolong Pharmaceuticals Artificial Blood Substitute Product and Services
Table 74. Prolong Pharmaceuticals Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Prolong Pharmaceuticals Recent Developments/Updates
Table 76. Prolong Pharmaceuticals Competitive Strengths & Weaknesses
Table 77. NuvOx Pharma Basic Information, Manufacturing Base and Competitors
Table 78. NuvOx Pharma Major Business
Table 79. NuvOx Pharma Artificial Blood Substitute Product and Services
Table 80. NuvOx Pharma Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. NuvOx Pharma Recent Developments/Updates
Table 82. NuvOx Pharma Competitive Strengths & Weaknesses
Table 83. Global Key Players of Artificial Blood Substitute Upstream (Raw Materials)
Table 84. Global Artificial Blood Substitute Typical Customers
Table 1. World Artificial Blood Substitute Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Artificial Blood Substitute Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Artificial Blood Substitute Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Artificial Blood Substitute Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Artificial Blood Substitute Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Artificial Blood Substitute Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Artificial Blood Substitute Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Artificial Blood Substitute Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Artificial Blood Substitute Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Artificial Blood Substitute Players in 2025
Table 12. World Artificial Blood Substitute Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Artificial Blood Substitute Company Evaluation Quadrant
Table 14. Head Office of Key Artificial Blood Substitute Players
Table 15. Artificial Blood Substitute Market: Company Product Type Footprint
Table 16. Artificial Blood Substitute Market: Company Product Application Footprint
Table 17. Artificial Blood Substitute Mergers & Acquisitions Activity
Table 18. United States VS China Artificial Blood Substitute Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Artificial Blood Substitute Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Artificial Blood Substitute Companies, Headquarters (States, Country)
Table 21. United States Based Companies Artificial Blood Substitute Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Artificial Blood Substitute Revenue Market Share (2021-2026)
Table 23. China Based Artificial Blood Substitute Companies, Headquarters (Province, Country)
Table 24. China Based Companies Artificial Blood Substitute Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Artificial Blood Substitute Revenue Market Share (2021-2026)
Table 26. Rest of World Based Artificial Blood Substitute Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Artificial Blood Substitute Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Artificial Blood Substitute Revenue Market Share (2021-2026)
Table 29. World Artificial Blood Substitute Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Artificial Blood Substitute Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Artificial Blood Substitute Market Size by Type (2027-2032) & (USD Million)
Table 32. World Artificial Blood Substitute Market Size by Stage, (USD Million), 2021 & 2025 & 2032
Table 33. World Artificial Blood Substitute Market Size Value by Stage (2021-2026) & (USD Million)
Table 34. World Artificial Blood Substitute Market Size by Stage (2027-2032) & (USD Million)
Table 35. World Artificial Blood Substitute Market Size by Product Form, (USD Million), 2021 & 2025 & 2032
Table 36. World Artificial Blood Substitute Market Size Value by Product Form (2021-2026) & (USD Million)
Table 37. World Artificial Blood Substitute Market Size by Product Form (2027-2032) & (USD Million)
Table 38. World Artificial Blood Substitute Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Artificial Blood Substitute Market Size by Application (2021-2026) & (USD Million)
Table 40. World Artificial Blood Substitute Market Size by Application (2027-2032) & (USD Million)
Table 41. Perftoran Basic Information, Manufacturing Base and Competitors
Table 42. Perftoran Major Business
Table 43. Perftoran Artificial Blood Substitute Product and Services
Table 44. Perftoran Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Perftoran Recent Developments/Updates
Table 46. Perftoran Competitive Strengths & Weaknesses
Table 47. HbO2 Therapeutics Basic Information, Manufacturing Base and Competitors
Table 48. HbO2 Therapeutics Major Business
Table 49. HbO2 Therapeutics Artificial Blood Substitute Product and Services
Table 50. HbO2 Therapeutics Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. HbO2 Therapeutics Recent Developments/Updates
Table 52. HbO2 Therapeutics Competitive Strengths & Weaknesses
Table 53. Aurum Biosciences Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Aurum Biosciences Ltd. Major Business
Table 55. Aurum Biosciences Ltd. Artificial Blood Substitute Product and Services
Table 56. Aurum Biosciences Ltd. Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Aurum Biosciences Ltd. Recent Developments/Updates
Table 58. Aurum Biosciences Ltd. Competitive Strengths & Weaknesses
Table 59. Hemarina Basic Information, Manufacturing Base and Competitors
Table 60. Hemarina Major Business
Table 61. Hemarina Artificial Blood Substitute Product and Services
Table 62. Hemarina Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Hemarina Recent Developments/Updates
Table 64. Hemarina Competitive Strengths & Weaknesses
Table 65. KaloCyte Inc. Basic Information, Manufacturing Base and Competitors
Table 66. KaloCyte Inc. Major Business
Table 67. KaloCyte Inc. Artificial Blood Substitute Product and Services
Table 68. KaloCyte Inc. Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. KaloCyte Inc. Recent Developments/Updates
Table 70. KaloCyte Inc. Competitive Strengths & Weaknesses
Table 71. Prolong Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 72. Prolong Pharmaceuticals Major Business
Table 73. Prolong Pharmaceuticals Artificial Blood Substitute Product and Services
Table 74. Prolong Pharmaceuticals Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Prolong Pharmaceuticals Recent Developments/Updates
Table 76. Prolong Pharmaceuticals Competitive Strengths & Weaknesses
Table 77. NuvOx Pharma Basic Information, Manufacturing Base and Competitors
Table 78. NuvOx Pharma Major Business
Table 79. NuvOx Pharma Artificial Blood Substitute Product and Services
Table 80. NuvOx Pharma Artificial Blood Substitute Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. NuvOx Pharma Recent Developments/Updates
Table 82. NuvOx Pharma Competitive Strengths & Weaknesses
Table 83. Global Key Players of Artificial Blood Substitute Upstream (Raw Materials)
Table 84. Global Artificial Blood Substitute Typical Customers
LIST OF FIGURES
Figure 1. Artificial Blood Substitute Picture
Figure 2. World Artificial Blood Substitute Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Artificial Blood Substitute Total Revenue (2021-2032) & (USD Million)
Figure 4. World Artificial Blood Substitute Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Artificial Blood Substitute Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Artificial Blood Substitute Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Artificial Blood Substitute Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Artificial Blood Substitute Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Artificial Blood Substitute Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Artificial Blood Substitute Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Artificial Blood Substitute Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Artificial Blood Substitute Revenue (2021-2032) & (USD Million)
Figure 13. Artificial Blood Substitute Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 16. World Artificial Blood Substitute Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 18. China Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 23. India Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Artificial Blood Substitute by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Artificial Blood Substitute Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Artificial Blood Substitute Markets in 2025
Figure 27. United States VS China: Artificial Blood Substitute Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Artificial Blood Substitute Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Artificial Blood Substitute Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Artificial Blood Substitute Market Size Market Share by Type in 2025
Figure 31. Perfluorocarbon-based Oxygen Carrier (PFBOC)
Figure 32. Hemoglobin-based Oxygen Carrier (HBOC)
Figure 33. World Artificial Blood Substitute Market Size Market Share by Type (2021-2032)
Figure 34. World Artificial Blood Substitute Market Size by Stage, (USD Million), 2021 & 2025 & 2032
Figure 35. World Artificial Blood Substitute Market Size Market Share by Stage in 2025
Figure 36. Preclinical Stage
Figure 37. Clinical Trial Stage
Figure 38. Commercialization
Figure 39. World Artificial Blood Substitute Market Size Market Share by Stage (2021-2032)
Figure 40. World Artificial Blood Substitute Market Size by Product Form, (USD Million), 2021 & 2025 & 2032
Figure 41. World Artificial Blood Substitute Market Size Market Share by Product Form in 2025
Figure 42. Solution-Based
Figure 43. Emulsion-Based
Figure 44. Others
Figure 45. World Artificial Blood Substitute Market Size Market Share by Product Form (2021-2032)
Figure 46. World Artificial Blood Substitute Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Artificial Blood Substitute Market Size Market Share by Application in 2025
Figure 48. Military
Figure 49. Civil
Figure 50. World Artificial Blood Substitute Market Size Market Share by Application (2021-2032)
Figure 51. Artificial Blood Substitute Industrial Chain
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Artificial Blood Substitute Picture
Figure 2. World Artificial Blood Substitute Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Artificial Blood Substitute Total Revenue (2021-2032) & (USD Million)
Figure 4. World Artificial Blood Substitute Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Artificial Blood Substitute Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Artificial Blood Substitute Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Artificial Blood Substitute Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Artificial Blood Substitute Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Artificial Blood Substitute Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Artificial Blood Substitute Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Artificial Blood Substitute Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Artificial Blood Substitute Revenue (2021-2032) & (USD Million)
Figure 13. Artificial Blood Substitute Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 16. World Artificial Blood Substitute Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 18. China Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 23. India Artificial Blood Substitute Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Artificial Blood Substitute by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Artificial Blood Substitute Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Artificial Blood Substitute Markets in 2025
Figure 27. United States VS China: Artificial Blood Substitute Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Artificial Blood Substitute Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Artificial Blood Substitute Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Artificial Blood Substitute Market Size Market Share by Type in 2025
Figure 31. Perfluorocarbon-based Oxygen Carrier (PFBOC)
Figure 32. Hemoglobin-based Oxygen Carrier (HBOC)
Figure 33. World Artificial Blood Substitute Market Size Market Share by Type (2021-2032)
Figure 34. World Artificial Blood Substitute Market Size by Stage, (USD Million), 2021 & 2025 & 2032
Figure 35. World Artificial Blood Substitute Market Size Market Share by Stage in 2025
Figure 36. Preclinical Stage
Figure 37. Clinical Trial Stage
Figure 38. Commercialization
Figure 39. World Artificial Blood Substitute Market Size Market Share by Stage (2021-2032)
Figure 40. World Artificial Blood Substitute Market Size by Product Form, (USD Million), 2021 & 2025 & 2032
Figure 41. World Artificial Blood Substitute Market Size Market Share by Product Form in 2025
Figure 42. Solution-Based
Figure 43. Emulsion-Based
Figure 44. Others
Figure 45. World Artificial Blood Substitute Market Size Market Share by Product Form (2021-2032)
Figure 46. World Artificial Blood Substitute Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Artificial Blood Substitute Market Size Market Share by Application in 2025
Figure 48. Military
Figure 49. Civil
Figure 50. World Artificial Blood Substitute Market Size Market Share by Application (2021-2032)
Figure 51. Artificial Blood Substitute Industrial Chain
Figure 52. Methodology
Figure 53. Research Process and Data Source
